Home › Funds › 683 Capital Management, LLC › QURE

683 Capital Management, LLC position in QURE

UNIQURE NV · Health Care

683 Capital Management, LLC reported holding 316,200 shares of QURE (UNIQURE NV) in its Q2 2026 13F filing — a position valued at US$14.6M, representing 0.77% of its reported portfolio and ranking #29 among its reported holdings. 683 Capital Management, LLC has disclosed QURE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)316.20K sh
Reported value held$14.56M
Portfolio Weight0.77%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 683 Capital Management, LLC's QURE position evolved

683 Capital Management, LLC first disclosed a stake in QURE in Q3 2023 at 1,575,000 shares (US$10.6M). The position peaked in Q3 2025 at 1,070,000 shares, worth US$62.5M. Across 12 filings, 683 Capital Management, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 316,200 shares valued at US$14.6M — a reduction of -183,800 shares quarter over quarter.. Notable position changes include a 98% trim in Q2 2025 (shares rose 319% over the following quarter), a 2753% increase in Q3 2025 (shares fell 59% over the following quarter), a 64% trim in Q4 2025 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.57M $10.57M New
Q4 2023 1.69M $11.46M Add
Q1 2024 1.98M $10.27M Add
Q2 2024 1.90M $8.51M Reduce
Q3 2024 1.85M $9.12M Reduce
Q4 2024 1.52M $26.93M Reduce
Q1 2025 1.55M $16.43M Add
Q2 2025 37.50K $522.75K Reduce
Q3 2025 1.07M $62.46M Add
Q4 2025 384.95K $9.21M Reduce
Q1 2026 500.00K $8.17M Add
Q2 2026 316.20K $14.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QURE and 13F data

QURE (UNIQURE NV) is a Health Care company. 64 other funds we track also report a position in QURE — the largest reported positions include Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), ORBIMED ADVISORS LLC (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QURE

All QURE fund holders →

FAQ

How long has 683 Capital Management, LLC held QURE?

683 Capital Management, LLC has disclosed QURE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is 683 Capital Management, LLC's current position in QURE?

As of Q2 2026, 683 Capital Management, LLC holds 316.20K shares of QURE (UNIQURE NV), valued at $14.56M, representing 0.77% of its reported portfolio and ranking #29.

Has 683 Capital Management, LLC been buying or selling QURE?

In the latest 13F filing (Q2 2026), 683 Capital Management, LLC reduced its position in QURE. The position peaked in Q3 2025 at 1.07M shares.

Which other funds hold QURE?

Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.